PLCgamma2: where bone and immune cells find their common ground

Area of Science:

• Immunology
• Bone Biology
• Cell Signaling

Background:

• Inflammatory arthritis involves complex interactions between bone and immune systems.
• Identifying shared signaling pathways is key for developing effective therapeutics.
• Phospholipase C gamma 2 (PLCgamma2) has emerged as a potential target due to its roles in both systems.

Purpose of the Study:

• To investigate the role of PLCgamma2 in modulating bone homeostasis and immune cell function.
• To explore PLCgamma2 as a therapeutic target for inflammatory conditions like arthritis.

Main Methods:

• Analysis of PLCgamma2's catalytic and adapter domain functions.
• Assessment of RANKL and integrin-dependent signaling pathways.
• Evaluation of osteoclast recruitment and function in PLCgamma2-deficient mice.
• Investigation of neutrophil degranulation and inflammatory arthritis models (K/BxN serum transfer).

Main Results:

• Mice lacking PLCgamma2 exhibit osteopetrosis, indicating impaired bone resorption.
• PLCgamma2 deficiency protects against K/BxN serum transfer arthritis, dependent on neutrophil activation.
• PLCgamma2 regulates signaling pathways crucial for osteoclast and neutrophil function.

Conclusions:

• PLCgamma2 is a critical regulator of cellular and molecular mechanisms in bone and immune cells during autoimmune inflammation.
• Targeting PLCgamma2 presents a promising therapeutic strategy for inflammatory arthritis and related diseases.